Apr 20, 2020
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
Mar 17, 2020
OncoSec Announces Publication of Positive TAVO(TM) Monotherapy Results in Metastatic Melanoma Patients in Annals of Oncology
Feb 04, 2020
Clinical Cancer Research highlights OncoSec's Merkel Cell Carcinoma Clinical Study on the Cover of its February Issue
Nov 08, 2019
Oxford BioDynamics' EpiSwitch(TM) Featured in Presentations on Development and Validation of Blood-Based Predictive Biomarkers in Immune Checkpoint Inhibitor Programs
Oct 22, 2019
Exploratory Analysis Reports Efficacy and Safety of BAVENCIO® (avelumab) Over Three Years in Previously Treated Metastatic Merkel Cell Carcinoma
Jun 04, 2018
Two Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO® (avelumab)
May 16, 2018
Merck KGaA, Darmstadt, Germany Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline
Feb 22, 2018
Health Canada Approves BAVENCIO(TM) (Avelumab for Injection) for the Treatment of Metastatic Merkel Cell Carcinoma (MCC) in Previously Treated Adult Patients
Nov 28, 2017
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer
Nov 28, 2017
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer
Nov 06, 2017
Debiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors including Non-Small Cell Lung Cancer (NSCLC)
Sep 27, 2017
Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan
Sep 21, 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Aug 30, 2017
Merck KGaA, Darmstadt, Germany: Driving Innovation in Cancer Care at ESMO 2017 With New Data in Hard-to-Treat Cancers
Jul 24, 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Jul 21, 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma